Last reviewed · How we verify
Drug resistant tuberculosis
Approved treatments
- Sirturo · Janssen Therap
Sirturo works by blocking the potassium voltage-gated channel subfamily H member 2, which is essential for the survival of Mycobacterium tuberculosis bacteria. - Deltyba · Pfizer Inc.
Clinical guidelines
- FDA label — 2L
SIRTURO is indicated as part of combination therapy in the treatment of adult and pediatric patients (2 years and older and weighing at least 8 kg) with pulmonary tuberculosis (TB) due to Mycobacterium tuberculosis resistant to at least rifampin and isoniazid. - FDA label — 2L
SIRTURO is indicated as part of combination therapy in the treatment of adult and pediatric patients (2 years and older and weighing at least 8 kg) with pulmonary tuberculosis (TB) due to Mycobacterium tuberculosis resistant to at least rifampin and isoniazid.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Drug resistant tuberculosis patent landscape — cliff calendar, originator estates, attackable patents
- Drug resistant tuberculosis treatment landscape brief
- Drug resistant tuberculosis treatment updates RSS
Frequently asked questions about Drug resistant tuberculosis
What drugs treat Drug resistant tuberculosis?
Tracked treatments include Sirturo, Deltyba.
What is the treatment for Drug resistant tuberculosis?
Standard treatment for Drug resistant tuberculosis includes Sirturo, Deltyba. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Drug resistant tuberculosis?
FDA label publishes guidelines for Drug resistant tuberculosis. 2 guideline references tracked.
Related
- Treatment landscape: Drug resistant tuberculosis patent cliff · Drug resistant tuberculosis CI report
- Treatment: Sirturo · Janssen Therap
- Treatment: Deltyba · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing